Ad is loading...
LMCPX
Price
$36.53
Change
-$0.31 (-0.84%)
Updated
Nov 15 closing price
MVCAX
Price
$35.14
Change
-$0.23 (-0.65%)
Updated
Nov 15 closing price
Ad is loading...

LMCPX vs MVCAX

Header iconLMCPX vs MVCAX Comparison
Open Charts LMCPX vs MVCAXBanner chart's image
Lord Abbett Mid Cap Stock P
Price$36.53
Change-$0.31 (-0.84%)
VolumeN/A
CapitalizationN/A
MFS Mid Cap Value A
Price$35.14
Change-$0.23 (-0.65%)
VolumeN/A
CapitalizationN/A
LMCPX vs MVCAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LMCPX vs. MVCAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMCPX is a Buy and MVCAX is a Buy.

FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 17.9B vs. LMCPX (1.23B). MVCAX pays higher dividends than LMCPX: MVCAX (1.16) vs LMCPX (0.32). LMCPX was incepted earlier than MVCAX: LMCPX (27 years) vs MVCAX (23 years). LMCPX is a more actively managed with annual turnover of: 41.00 vs. MVCAX (19.00). LMCPX has a lower initial minimum investment than MVCAX: LMCPX (0) vs MVCAX (1000). LMCPX annual gain was more profitable for investors over the last year : 28.55 vs. MVCAX (26.84). MVCAX return over 5 years is better than : 49.25 vs. LMCPX (34.66).
LMCPXMVCAXLMCPX / MVCAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years23 years-
Gain YTD18.41217.801103%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.23B17.9B7%
Annual Yield % from dividends0.321.1628%
Returns for 1 year28.5526.84106%
Returns for 3 years3.328.5539%
Returns for 5 years34.6649.2570%
Returns for 10 years53.3378.6468%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HOUS3.970.02
+0.51%
Anywhere Real Estate
JKHY173.210.76
+0.44%
Jack Henry & Associates
YELP35.95-0.48
-1.32%
YELP
GTBP2.92-0.09
-2.99%
GT Biopharma
TELA2.92-0.12
-3.95%
TELA Bio